To date, one of the most promising strategies for targeting HNSCC CSCs is blocking the key self-renewal signaling cascades, such as those regulated by EGFR, NOTCH, WNT, and SHH. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.